EUROPEAN PATENT APPLICATION GRANTED FOR INHIBITORS OF THE uPAR/FPRs RECEPTOR INTERACTION
Rome, 7 January 2026 – Cube Labs S.p.A. (“Cube Labs” or the “Company”) – an Italian venture builder in the healthcare technology sector listed on Euronext Growth Milan, Professional Segment…
